Functional Characterization of Polymorphisms in the Peptidase Inhibitor 3 (Elafin) Gene and Validation of Their Contribution to Risk of Acute Respiratory Distress Syndrome

被引:19
|
作者
Tejera, Paula [1 ]
O'Mahony, D. Shane [2 ]
Owen, Caroline A. [3 ,4 ]
Wei, Yongyue [1 ]
Wang, Zhaoxi [1 ]
Gupta, Kushagra [3 ]
Su, Li [1 ]
Villar, Jesus [5 ,6 ]
Wurfel, Mark [2 ]
Christiani, David C. [1 ,7 ]
机构
[1] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[2] Univ Washington, Harborview Med Ctr, Seattle, WA 98104 USA
[3] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA
[4] Lovelace Resp Res Inst, Albuquerque, NM USA
[5] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Resp, Madrid, Spain
[6] Hosp Univ Dr Negrin, Res Unit, Las Palmas Gran Canaria, Spain
[7] Massachusetts Gen Hosp, Boston, MA 02114 USA
关键词
acute respiratory distress syndrome; elafin; single-nucleotide polymorphism; genetic association; replication; ACUTE LUNG INJURY; ELASTASE-SPECIFIC INHIBITOR; LEUKOCYTE PROTEASE INHIBITOR; NEUTROPHIL ELASTASE; PRE-ELAFIN; PROTEINASE-INHIBITOR; HUMAN KERATINOCYTES; EPITHELIAL-CELLS; BACTERIAL LIPOPOLYSACCHARIDE; PSEUDOMONAS-AERUGINOSA;
D O I
10.1165/rcmb.2013-0238OC
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Elafin (peptidase inhibitor 3 [PI3]) and its biologically active precursor, pre-elafin, are neutrophil serine proteinase inhibitors with an important role in preventing excessive tissue injury during inflammatory events. Recently, we reported an association between single-nucleotide polymorphism (SNP) rs2664581 in the PI3 gene, increased risk of acute respiratory distress syndrome (ARDS) and pre-elafin circulating levels. This study aims to validate the legitimacy of this association by using a cohort of patients who met the criteria for systemic inflammatory response syndrome and were at risk of developing ARDS (n = 840). A comprehensive functional study of SNPs in PI3 gene was also performed. Luciferase assays and electrophoretic mobility shift assays were conducted to determine the functional relevance of promoter region variants. The effect of the coding SNP rs2664581 on the neutrophil elastase inhibitory activity and transglutaminase binding properties of pre-elafin was also investigated. The variant allele of rs2664581 (C) was significantly associated with increased ARDS risk, mainly among subjects with sepsis (odds ratio = 1.44; 95% confidence interval = 1.04-1.99; P = 0.0276, adjusted by age, sex, and Acute Physiology and Chronic Health Evaluation III). Pre-elafin recombinant protein carrying the amino acid change associated with rs2664581 (Thr34Pro, mutant protein [MT]) had greater capacity to undergo transglutaminase-mediated cross-linking to immobilized fibronectin than wild-type protein in vitro (P < 0.003). No differences were observed in the neutrophil elastase inhibitory activities of wild-type versus MT proteins. In addition, the risk allele-promoter construct had significantly lower cytokine-induced transcriptional activity. Electrophoretic mobility shift assay results indicated a differential binding of nuclear proteins to the G and A alleles of SNP -338G. A. Our results confirm the association between SNP rs2664581 and enhanced risk of ARDS, further supporting the role of PI3 in ARDS development. SNPs in the PI3 locus may act synergistically by regulating PI3 gene expression and pre-elafin biological functions.
引用
收藏
页码:262 / 272
页数:11
相关论文
共 49 条
  • [41] Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
    Dixon, Barry
    Smith, Roger J.
    Campbell, Duncan J.
    Moran, John L.
    Doig, Gordon S.
    Rechnitzer, Thomas
    MacIsaac, Christopher M.
    Simpson, Nicholas
    van Haren, Frank M. P.
    Ghosh, Angajendra N.
    Gupta, Sachin
    Broadfield, Emma J. C.
    Crozier, Timothy M. E.
    French, Craig
    Santamaria, John D.
    LANCET RESPIRATORY MEDICINE, 2021, 9 (04): : 360 - 372
  • [42] Functional and Radiological Follow-Up at 3 Months of Acute Respiratory Distress Syndrome Related to SARS-Cov2 in Intensive Care Unit Patients
    Pasau, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [43] Ethnic and age-specific acute lung injury/acute respiratory distress syndrome risk associated with angiotensin-converting enzyme insertion/deletion polymorphisms, implications for COVID-19: A meta-analysis
    Pabalan, Noel
    Tharabenjasin, Phuntila
    Suntornsaratoon, Panan
    Jarjanazi, Hamdi
    Muanprasat, Chatchai
    INFECTION GENETICS AND EVOLUTION, 2021, 88
  • [44] Assessment of Ventilatory Heterogeneity by Measures Derived From 3D Functional Electrical Impedance Imaging of Patients With Acute Respiratory Distress Syndrome and Healthy Controls: A Pilot Study
    Da Rosa, N. Barbosa
    Brinton, J.
    Pigatto, A. Vieira
    Kao, T.
    Offner, P.
    Mueller, J. L.
    Burnham, E. L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [45] RETRACTION: Serum sphingosine-1-phosphate levels and Sphingosine-1-Phosphate gene polymorphisms in acute respiratory distress syndrome: a multicenter prospective study (Retraction of Vol 18, art no 156, 2020)
    Zhao, Jiangnan
    Tan, Yan
    Wang, Li
    Su, Xin
    Shi, Yi
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [46] The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS) (Aug, 10.1038/s41375-021-01374-3, 2021)
    Neubauer, Andreas
    Johow, Johannes
    Mack, Elisabeth
    Burchert, Andreas
    Meyn, Damaris
    Kadlubiec, Andrea
    Torje, Iuliu
    Wulf, Hinnerk
    Vogelmeier, Claus F.
    Hoyer, Joachim
    Skevaki, Chrysanthi
    Muellenbach, Ralf Michael
    Keller, Christian
    Schade-Brittinger, Carmen
    Rolfes, Caroline
    Wiesmann, Thomas
    LEUKEMIA, 2021, 35 (10) : 3038 - 3038
  • [47] A PILOT STUDY ON THE EFFECTS OF PERIOPERARTIVE ADMINISTRATION OF THE NEUTROPHIL ELASTASE INHIBITOR, SIVELESTAT, TO NON-SMALL CELL LUNG CANCER PATIENTS WITH PREOPERATIVE RISK FACTORS OF ACUTE RESPIRATORY DISTRESS SYNDROME AFTER PULMONARY RESECTION
    Kometani, Takuro
    Okamoto, Tatsuro
    Yoshida, Shigetoshi
    Yoshino, Ichiro
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S812 - S812
  • [48] RETRACTED: Serum sphingosine-1-phosphate levels and Sphingosine-1-Phosphate gene polymorphisms in acute respiratory distress syndrome: a multicenter prospective study (Retracted article. See vol. 20, 2022)
    Zhao, Jiangnan
    Tan, Yan
    Wang, Li
    Su, Xin
    Shi, Yi
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [49] A Randomized Dose-Escalation Study of the Safety and Anti-Inflammatory Activity of the p38 Mitogen-Activated Protein Kinase Inhibitor Dilmapimod in Severe Trauma Subjects at Risk for Acute Respiratory Distress Syndrome
    Christie, Jason D.
    Vaslef, Steven
    Chang, Philip K.
    May, Addison K.
    Gunn, Scott R.
    Yang, Shuying
    Hardes, Kelly
    Kahl, Lesley
    Powley, William M.
    Lipson, David A.
    Bayliffe, Andrew I.
    Lazaar, Aili L.
    CRITICAL CARE MEDICINE, 2015, 43 (09) : 1859 - 1869